Philips Enables Digitization of Tumor Tissue Research at Institut Curie to Combat Cancer

Royal Philips ElectronicsPhilips is collaborating with Institut Curie who is now able to digitize tumor analysis research, with the aim of speeding up and improving cancer diagnosis and treatment. Today pathologists view tissue sample images manually using a microscope. By using Philips Digital Pathology Solution, Institut Curie hopes to increase workflow efficiency and consolidate its pathology activities at multiple sites into one single virtual laboratory.

As well as the diagnosis of tissue from patients with cancer indications, the pathology department at Institut Curie evaluates thousands of test samples from experimental cancer research programs worldwide to gain a better understanding of the causes and mechanisms of diseases at both cellular and molecular level. These new insights may give rise to new diagnostic approaches and therapeutic treatments.

Currently, Institut Curie produces and diagnoses more than 200,000 glass pathology slides every year using a microscope. Digitalization of the pathology workflow could ease this logistical burden and enable new ways of working, such as real-time collaboration with peers and creation of a virtual network across the globe. Moreover, in cancer research, digital histopathology information can now, for example, be added to biology data and this opens up new ways to mine information from tumor tissue for further data analysis.

"Digitalization of pathology will enable us to keep momentum going to accelerate cancer research and, in the end, improve patient care," says Xavier Sastre-Garau, director of the Biopathology Department of Institut Curie.

"Philips' digital pathology solution is empowering Institut Curie to realize a single virtual laboratory that offers new opportunities for intensive collaboration," says Guido du Pree, vice president of Marketing & Sales for Philips Digital Pathology Solutions.

To support its cancer research, Insitut Curie has completed installation of the fully integrated Philips Digital Pathology Solution with ultrafast scanners at its locations in Paris and St. Cloud, which are connected on-line through an image management system that provides an interface to communicate with commercially available Laboratory Information Systems (LIS). Institut Curie benefited for this acquisition from the support of the National Cancer Institute, SiRIC grant with reference "INCa-DGOS-4654".

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...

New Medical AI Tool Identifies more Case…

Investigators at Mass General Brigham have developed an AI-based tool to sift through electronic health records to help clinicians identify cases of long COVID, an often mysterious condition that can...